CN117279521A - 用于抑制破骨前体细胞分化为破骨细胞的组合物及用于改善骨代谢的组合物 - Google Patents

用于抑制破骨前体细胞分化为破骨细胞的组合物及用于改善骨代谢的组合物 Download PDF

Info

Publication number
CN117279521A
CN117279521A CN202280032086.9A CN202280032086A CN117279521A CN 117279521 A CN117279521 A CN 117279521A CN 202280032086 A CN202280032086 A CN 202280032086A CN 117279521 A CN117279521 A CN 117279521A
Authority
CN
China
Prior art keywords
composition
treated product
lactobacillus plantarum
cells
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280032086.9A
Other languages
English (en)
Chinese (zh)
Inventor
中嶋翼
北村幸平
中井宽子
广濑义隆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
House Wellness Foods Corp
Original Assignee
House Wellness Foods Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by House Wellness Foods Corp filed Critical House Wellness Foods Corp
Publication of CN117279521A publication Critical patent/CN117279521A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/72—Undefined extracts from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN202280032086.9A 2021-05-17 2022-03-22 用于抑制破骨前体细胞分化为破骨细胞的组合物及用于改善骨代谢的组合物 Pending CN117279521A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021083347 2021-05-17
JP2021-083347 2021-05-17
PCT/JP2022/013051 WO2022244447A1 (ja) 2021-05-17 2022-03-22 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物

Publications (1)

Publication Number Publication Date
CN117279521A true CN117279521A (zh) 2023-12-22

Family

ID=84141538

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280032086.9A Pending CN117279521A (zh) 2021-05-17 2022-03-22 用于抑制破骨前体细胞分化为破骨细胞的组合物及用于改善骨代谢的组合物

Country Status (6)

Country Link
US (1) US20240252559A1 (https=)
EP (2) EP4700115A2 (https=)
JP (2) JP7533830B2 (https=)
CN (1) CN117279521A (https=)
TW (1) TW202313077A (https=)
WO (1) WO2022244447A1 (https=)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11228425A (ja) * 1998-02-13 1999-08-24 Takeda Food Products Ltd Ｉｌ−１２産生誘導組成物
US20100098728A1 (en) * 2008-10-16 2010-04-22 Takashi Fujiki Immunostimulating composition containing Lactic Acid bacteria
WO2013176327A1 (ko) * 2012-05-25 2013-11-28 한국한의학연구원 황련해독탕의 유산균 발효물을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학적 조성물 및 건강기능식품
JP2015096476A (ja) * 2013-11-15 2015-05-21 株式会社東洋新薬 コラーゲン産生促進用組成物、コラーゲン吸収促進用組成物、抗肥満用組成物
KR101554875B1 (ko) * 2015-01-09 2015-09-24 (주) 와이디생명과학 락토바실러스 플란타룸 yd-212 균주 및 이를 이용하여 제조되는 발효물을 포함하는 조성물
KR20160086249A (ko) * 2015-07-27 2016-07-19 (주) 와이디생명과학 락토바실러스 플란타룸 yd-212 균주 및 이를 이용하여 제조되는 발효물을 포함하는 조성물
JP2017114814A (ja) * 2015-12-24 2017-06-29 丸善製薬株式会社 化粧料
CN111163788A (zh) * 2017-09-01 2020-05-15 好侍健康食品株式会社 用于促进透明质酸生成的组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5207313B2 (ja) 2008-05-30 2013-06-12 有限会社バイオメディカルリサーチグループ 乳酸菌配合物及びその製造方法
JP2010235534A (ja) 2009-03-31 2010-10-21 Fancl Corp 骨粗鬆症の予防又は治療用剤

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11228425A (ja) * 1998-02-13 1999-08-24 Takeda Food Products Ltd Ｉｌ−１２産生誘導組成物
US20100098728A1 (en) * 2008-10-16 2010-04-22 Takashi Fujiki Immunostimulating composition containing Lactic Acid bacteria
WO2013176327A1 (ko) * 2012-05-25 2013-11-28 한국한의학연구원 황련해독탕의 유산균 발효물을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학적 조성물 및 건강기능식품
JP2015096476A (ja) * 2013-11-15 2015-05-21 株式会社東洋新薬 コラーゲン産生促進用組成物、コラーゲン吸収促進用組成物、抗肥満用組成物
KR101554875B1 (ko) * 2015-01-09 2015-09-24 (주) 와이디생명과학 락토바실러스 플란타룸 yd-212 균주 및 이를 이용하여 제조되는 발효물을 포함하는 조성물
KR20160086249A (ko) * 2015-07-27 2016-07-19 (주) 와이디생명과학 락토바실러스 플란타룸 yd-212 균주 및 이를 이용하여 제조되는 발효물을 포함하는 조성물
JP2017114814A (ja) * 2015-12-24 2017-06-29 丸善製薬株式会社 化粧料
CN111163788A (zh) * 2017-09-01 2020-05-15 好侍健康食品株式会社 用于促进透明质酸生成的组合物
US20200353020A1 (en) * 2017-09-01 2020-11-12 House Wellness Foods Corporation Composition for promoting hyaluronic acid production

Also Published As

Publication number Publication date
EP4342535A1 (en) 2024-03-27
EP4342535A4 (en) 2025-04-23
JP2024075769A (ja) 2024-06-04
EP4700115A2 (en) 2026-02-25
JP7586361B2 (ja) 2024-11-19
JPWO2022244447A1 (https=) 2022-11-24
JP7533830B2 (ja) 2024-08-14
TW202313077A (zh) 2023-04-01
US20240252559A1 (en) 2024-08-01
WO2022244447A1 (ja) 2022-11-24

Similar Documents

Publication Publication Date Title
US9504720B2 (en) Substance for preventing and improving arthritis
US12059442B2 (en) Obesity treatment using probiotics, composition for reducing body fat, and composition for reducing waist circumference
KR20210022221A (ko) 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도
JP5337535B2 (ja) Ｎｋ活性増強剤
CN114786692A (zh) 用于调节肠道免疫的新型益生菌组合物
JP6767157B2 (ja) インターフェロンλ誘導剤
WO2018190407A1 (ja) Ｔｏｌｌ様受容体２活性化用組成物
AU2006215205B2 (en) Composition for immunostimulation
WO2015046407A1 (ja) 免疫疾患予防剤
WO2020067422A1 (ja) Ｔ細胞を活性化するための組成物
JP5209294B2 (ja) インターロイキン１２産生促進剤
JP2019077694A (ja) 免疫疾患予防剤
TWI705135B (zh) 抗齲齒劑及抗齲齒用組成物
JP7586361B2 (ja) 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物
WO2025022830A1 (ja) 免疫機能を相乗的に増強する組成物
JP2014024776A (ja) Ｎａｓｈ予防治療剤
JP7331310B2 (ja) 免疫賦活活性を有する乳酸菌又はその処理物の保存時間経過による免疫賦活活性の低下を抑制するための組成物
WO2022065268A1 (ja) 乳酸菌と脂肪酸を含む飼料及び組成物
JP7663240B2 (ja) 腸管免疫賦活剤及びＩｇＡ産生促進剤
JP7706190B2 (ja) ブラウティア属細菌
JP7706191B2 (ja) ブラウティア属細菌を用いた免疫賦活剤
TWI838990B (zh) 腸管免疫賦活劑、IgA産生促進劑及基因表現促進劑
WO2025070283A1 (ja) ブラウティア属細菌を用いた免疫賦活剤
WO2025070280A1 (ja) ブラウティア属細菌
JP2026055457A (ja) ラクチプランチバチルス属乳酸菌を含む組成物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination